About
FimmCyte develops targeted immunotherapies for chronic fibro-inflammatory diseases such as endometriosis, using a platform that precisely eliminates diseased fibrotic tissue without affecting healthy cells.
Explore FimmCyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.